HOME ABOUT US CONTACT US SITEMAP
username:
password:
remember my password:

Having trouble logging in?
CLICK HERE

Not a member?
CLICK HERE

Archives

ISCT 2007
Sydney, Australia
June 24-27

Abstracts
Click here to view 2007 ISCT Annual Meeting Abstracts

Best Abstract Award Winner:
GENE MODIFICATION AT CLINICAL SCALE: ENGINEERING RESISTANCE TO HIV INFECTION VIA TARGETED DISRUPTION OF THE HIV CO-RECEPTOR CCR5 GENE IN CD4+ T CELLS USING MODIFIED ZINC FINGER PROTEIN NUCLEASES
B. L. Levine1, M. DeCaul1, O. Liu1, J. Wang2, G. Lee2, K. Kim2, N. Wang2, D. Ando2, P. D. Gregory2, J. L. Riley1, M. C. Holmes2, C. H. June1, E. E. Perez1;
1University of Pennsylvania, Philadelphia, PA, 2Sangamo BioSciences, Richmond, CA.

Program
To view a printable version of the 2007 program please click here.

Order the 2007 Plenary Sessions on CD!
Plenary sessions at the ISCT 2007 annual meeting have been audio recorded and will be burned to CD along with the PowerPoint presentations.
2007 Plenary Session CD Order Form


Post Conference Workshop
Global Harmonization of Cell Therapy-The Regulator’s Perspective 
Click here for presentations.


ISCT 2006
Berlin, Germany
May 4-7

2006 ISCT Annual Meeting Abstracts

Program Planner
To view full program details please click here.

Program
To view a printable version of the 2006 program please click here.

Cell Therapy Research Workshop Program
To view the program for the workshop on Monday, May 8, please click here.

ISCT 2006 Corporate Symposia

T-Cell-Based Immunotherapeutic Strategies
Sponsored by Dynal BBS, Invitrogen Corporation

Novel Routes in Cellular Therapy
Sponsored by Miltenyi Biotec GmbH

Advancing the Clinical Application of Adult Autologous Stem Cells in Cardiac Disease
Sponsored by Baxter

ISCT 2006 Corporate Tutorial

Immunoreconstitution of Antigene Specific T-cells Against CMV Post-Stem Cell Transplantation
Sponsored by Beckman Coulter


ISCT 2005
Vancouver, Canada
May 4-7

2005 ISCT Annual Meeting Abstracts

Best Abstract Award Winner:
IMMUNOBIOLOGY OF ALLOGENEIC TISSUE ENGINEERED NEOCARTILAGE: IMPLICATIONS FOR BIOLOGIC REPAIR OF JOINT ARTICULAR CARTILAGE.
P.R. Streeter1, X. Zhang1, C. Milliman2, H. Nochi3, H.D. Adkisson2
1Oregon Health & Science University, Portland, OR; 2ISTO Technologies, Inc., St. Louis, MO; 3Washington University School of Medicine, St. Louis, MO.

Program
To view a printable version of the program please click here.


ISCT 2004
Dublin, Ireland
May 8-10

Program
To view a printable version of the program please click here.

Best Abstract Award Winners:
A PHASE I CLINICAL TRIAL IN HIV POSITIVE PATIENT-SUBJECTS INFUSED WITH CD3/CD28-ACTIVATED AUTOLOGOUS CD4+ T CELLS MODIFIED WITH A LENTIVIRAL VECTOR.
B. L. Levine1, L. Humeau2, X. Lu2, V. Slepushkin2, C. Afable2, K. Schonely2, P. Manilla2, J. Cotte1, Z. Zheng1, K. Grandfield1, X. Shan1, R. Mair1, N. Chi1,
E. Veloso1, K. Lacy1, R. R. MacGregor1, B. Dropulic2,3, C. H. June1;
1University of Pennsylvania, Philadelphia, PA, 2Virxsys Corporation, Gaithersburg, MD, 3Sydney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.

MURINE MARROW STROMAL CELLS ENGRAFT, MIGRATE AND PRODUCE apoE IN THE BRAIN OF AN AD MOUSE MODEL.
A. Peister, R. L. Reger, J. A. Mellad, S. Zeitouni, D. J. Prockop;
Tulane University, New Orleans, LA.


ISCT 2003
Phoenix, USA
May 30-June 1 

Program
To view a printable version of the program please click here.

Best Abstract Award Winners:
ADOPTIVE TRANSFER OF TETRAMER SELECTED CYTOMEGALOVIRUS-SPECIFIC CYTOTOXIC T CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. M. Cobbold1, N. Khan1, S. Tauro2, D. McDonald3, H. Osman1, E. Olavarria4, J. M. Goldman4, R. Chakraverty1, P. Mahendra5, C. Craddock5, P. Moss1; 1CRUK Institute for Cancer Studies, Birmingham, UNITED KINGDOM, 2Birmingham Heartlands Hospital, Birmingham, UNITED KINGDOM, 3National Blood Transfusion Centre, Birmingham, UNITED KINGDOM, 4Hammersmith Hospital, London, UNITED KINGDOM, 5Univerity Hospital Birmingham, Birmingham, UNITED KINGDOM.

ENGRAFTMENT OF MURINE MESENCHYMAL STEM CELLS IN LUNG IS INCREASED IN RESPONSE TO BLEOMYCIN EXPOSURE AND RESULTS IN A DECREASE IN LUNG FIBROSIS LEADING TO A GENERALIZED IMPROVEMENT IN THE HEALTH STATUS OF MICE. D. G. Phinney1, L. A. Ortiz2, F. Gambelli2, C. McBride1, M. Baddoo1, D. Gaupp1; 1Center for Gene Therapy, Tulane University of the Health Sciences,, New Orleans, LA, 2Department of Environmental and Occupational Health, University of Pittsburg, Pittsburg, PA.


ISCT 2002
Barcelona, Spain
May 26-28 

Program
To view a printable version of the program please click here.